Showing results (121-130 of 285) with videos related to
Sort By:
Pageof 29
British Journal of Pharmacology|October 1, 1989
Lorazepam discontinuation promotes 'inverse agonist' effects of benzodiazepinesA Schatzki, F Lopez, D J Greenblatt, et al.Biopharmaceutics & Drug Disposition|April 1, 1997
Biotransformation of chlorzoxazone by hepatic microsomes from humans and ten other mammalian speciesM H Court, L L Von Moltke, R I Shader, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 13, 2001
Ritonavir, efavirenz, and nelfinavir inhibit CYP2B6 activity in vitro: potential drug interactions with bupropionL M Hesse, L L von Moltke, R I Shader, et al.The American Journal of Drug and Alcohol Abuse|January 1, 1977
The effect of marijuana on small group processC Salzman, G E Kochansky, B A Van Der Kolk, et al.Pharmacology|October 1, 1993
Alprazolam metabolism in vitro: studies of human, monkey, mouse, and rat liver microsomesL L von Moltke, D J Greenblatt, J S Harmatz, et al.Clinical Pharmacology and Therapeutics|February 1, 1976
Influence of magnesium and aluminum hydroxide mixture on chlordiazepoxide absorptionD J Greenblatt, R I Shader, J S Harmatz, et al.Psychopharmacology|January 1, 1984
Absolute bioavailability of imipramine: influence of foodD R Abernethyl, M Divoll, D J Greenblatt, et al.Journal of Clinical Pharmacology|August 14, 1998
Pharmacokinetics and pharmacodynamics of diphenhydramine 25 mg in young and elderly volunteersJ M Scavone, D J Greenblatt, J S Harmatz, et al.Journal of Neurochemistry|April 1, 1991
Modification of gamma-aminobutyric acidA receptor binding and function by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vitro and in vivo: effects of agingL G Miller, M Lumpkin, W R Galpern, et al.British Journal of Clinical Pharmacology|February 12, 1998
Inhibition of CYP2C9 by selective serotonin reuptake inhibitors in vitro: studies of phenytoin p-hydroxylationJ Schmider, D J Greenblatt, L L von Moltke, et al.Pageof 29